Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Inj delandistrogene mox rokl (OTHER 0714) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 28, 2026 , from http://ppman.hank.ai/transparency/procedure/0714/by-state?code_type=OTHER
“Inj delandistrogene mox rokl (OTHER 0714) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/0714/by-state?code_type=OTHER. Accessed
June 28, 2026 .
“Inj delandistrogene mox rokl (OTHER 0714) by State,” HANK Price Transparency ,
accessed June 28, 2026 ,
http://ppman.hank.ai/transparency/procedure/0714/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
0714 — Inj Delandistrogene Mox Rokl
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$3,316,463
National median
$3,255,346 – $3,374,501
IQR (p25 – p75)
14
hospitals filing
7
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 0714 (OTHER), with interquartile range
State Median p25 p75
ND $4,716,419 $4,426,350 $4,791,359
SD $4,591,518 $4,309,092 $4,664,408
CA $4,414,760 $4,140,816 $4,972,276
MI $3,316,463 $1,734,510 $3,316,463
NY $3,316,463 $3,316,463 $3,316,463
HI $3,255,346 $3,255,346 $3,421,435
NE $3,211,266 $3,185,256 $3,237,275